铂耐药复发性卵巢癌患者的生活质量、症状与照护需求:NRG肿瘤学/妇科肿瘤组研究
本研究前瞻性纳入102例持续或复发性铂耐药卵巢癌患者,在入组时、3个月和6个月评估症状负担与照护需求。结果显示最常见的疾病相关症状为疲乏(92%)、担忧(89%)和睡眠困难(76%),73%的患者被治疗副作用困扰;症状维度是未满足需求最常见的领域。结论认为疾病和治疗相关症状与未满足需求显著相关,且随时间无实质变化。
要点
- 铂耐药复发性卵巢癌患者中疲乏(92%)、担忧(89%)和睡眠困难(76%)是最常见的疾病相关症状。
- 73%的患者报告被治疗副作用困扰,其中恶心41%、脱发51%,两者随时间无变化。
- 症状维度是NEST未满足需求最常见的领域,症状与未满足需求存在显著关联。
核心结论
- 在接近生命终点的患者中,疾病和治疗相关症状与患者未满足的照护需求存在显著关联,且这些需求随时间无实质变化。
- 对终末照护需求进行细致探索可改善以患者为中心的照护和生活质量。
研究设计与样本
- 前瞻性试验,纳入估计预期寿命至少6个月的持续或复发性铂耐药卵巢癌女性患者。
- 共入组102例可评估患者,在入组时、3个月和6个月收集NEST、FACIT-Fatigue(FACIT-F)、NCCN-FACT卵巢症状指数(NFOSI-18)的疾病相关症状(DRS)、治疗副作用(TSE)和功能/ wellbeing(F/WB)等量表。
主要发现
- 启动不复苏(DNR)讨论的比例从入组时的28%升至6个月时的37%。
- 入组时最常见的疾病相关症状为疲乏(92%)、担忧(89%)和睡眠困难(76%)。
- 73%的患者报告被治疗副作用困扰,包括恶心(41%)和脱发(51%),两者随时间无变化。
- NEST未满足需求最常见于症状维度;社会维度与F/WB(p=0.002)和FACIT-F(p=0.006)相关。
- 症状维度与DRS(p=0.04)、TSE(p=0.03)和FACIT-F(p=0.04)相关;存在维度与任何患者报告症状均不相关;治疗维度与F/WB(p=0.02)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The goals of treating recurrent platinum-resistant ovarian cancer are palliative, aimed at reducing symptoms and improving progression free survival. A prospective trial was conducted to determine the prevalence and severity of symptoms, and associated care needs. METHODS: Eligible women included those with persistent or recurrent platinum-resistant ovarian cancer with an estimated life expectancy of at least 6 months. The Needs at the End-of-Life Screening Tool (NEST), FACIT-Fatigue (FACIT-F), NCCN-FACT Ovarian Symptom Index [NFOSI-18]; Disease Related Symptoms (DRS), Treatment Side Effects (TSE), and Function/Well Being (F/WB) were collected at study entry, 3 and 6 months. RESULTS: We enrolled 102 evaluable patients. Initiation of Do Not Resuscitate (DNR) discussions increased over time from 28% at study entry to 37% at 6 months. At study entry, the most common disease-related symptoms were fatigue (92%), worry (89%), and trouble sleeping (76%); 73% reported being "bothered by treatment side effects", which included nausea (41%) and hair loss (51%) neither of which changed over time. The most common NEST unmet needs were in the symptom dimension. The social dimension was associated with F/WB (p = 0.002) and FACIT-F (p = 0.006); symptoms were associated with DRS (p = 0.04), TSE (p = 0.03), and FACIT-F (p = 0.04); existential was not associated with any of the patient-reported symptoms; therapeutic was associated with F/WB (p = 0.02). CONCLUSIONS: In patients nearing the end of life, there are significant associations between disease and treatment related symptoms and unmet patient needs, which do not change substantially over time. Careful exploration of specific end-of-life care needs can improve patient-centered care and QOL.
引用
- von Gruenigen VE, Huang HQ, Cella D, et al. Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018. PMID: 29778506. doi:10.1016/j.ygyno.2018.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。